hydroquinone has been researched along with Lentigo in 9 studies
Lentigo: Small circumscribed melanoses resembling, but differing histologically from, freckles. The concept includes senile lentigo ('liver spots') and nevoid lentigo (nevus spilus, lentigo simplex) and may also occur in association with multiple congenital defects or congenital syndromes (e.g., Peutz-Jeghers syndrome).
| Excerpt | Relevance | Reference |
|---|---|---|
| "01% (Solagé) was compared with its active components, its vehicle, and hydroquinone (HQ) 3% in the treatment of solar lentigines." | 9.11 | Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines. ( Jarratt, M, 2004) |
| "To assess sensitive and objective methods predicting the effects of a 2% hydroquinone-cyclodextrin formulation on solar lentigines." | 9.10 | Analytic quantification of solar lentigines lightening by a 2% hydroquinone-cyclodextrin formulation. ( Petit, L; Piérard, GE, 2003) |
| "Although bleaching treatment using all-trans retinoic acid (RA) and hydroquinone (HQ) improves epidermal melanosis, the application of two medications and the irritant dermatitis induced by RA inconvenience patients." | 7.79 | Silicone sheet containing all-trans retinoic acid and hydroquinone for the treatment of epidermal melanosis. ( Harii, K; Iida, S; Kurita, M; Ohura, N; Sato, S; Takushima, A, 2013) |
| "01% (Solagé) was compared with its active components, its vehicle, and hydroquinone (HQ) 3% in the treatment of solar lentigines." | 5.11 | Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines. ( Jarratt, M, 2004) |
| "To assess sensitive and objective methods predicting the effects of a 2% hydroquinone-cyclodextrin formulation on solar lentigines." | 5.10 | Analytic quantification of solar lentigines lightening by a 2% hydroquinone-cyclodextrin formulation. ( Petit, L; Piérard, GE, 2003) |
| "Although bleaching treatment using all-trans retinoic acid (RA) and hydroquinone (HQ) improves epidermal melanosis, the application of two medications and the irritant dermatitis induced by RA inconvenience patients." | 3.79 | Silicone sheet containing all-trans retinoic acid and hydroquinone for the treatment of epidermal melanosis. ( Harii, K; Iida, S; Kurita, M; Ohura, N; Sato, S; Takushima, A, 2013) |
| "Hydroquinone is a well known reagent used in the treatment of pigmentation disorders." | 1.30 | Efficacy of topical treatment of pigmentation skin disorders with plant hydroquinone glucosides as assessed by quantitative color analysis. ( Barel, A; Clarys, P, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dreher, F | 1 |
| Draelos, ZD | 1 |
| Gold, MH | 1 |
| Goldman, MP | 1 |
| Fabi, SG | 1 |
| Puissegur Lupo, ML | 1 |
| Iida, S | 1 |
| Takushima, A | 1 |
| Ohura, N | 1 |
| Sato, S | 1 |
| Kurita, M | 1 |
| Harii, K | 1 |
| Hexsel, D | 1 |
| Hexsel, C | 1 |
| Porto, MD | 1 |
| Siega, C | 1 |
| Imhof, L | 1 |
| Dummer, R | 1 |
| Dreier, J | 1 |
| Kolm, I | 1 |
| Barysch, MJ | 1 |
| Petit, L | 1 |
| Piérard, GE | 1 |
| Jarratt, M | 1 |
| Cayce, KA | 1 |
| McMichael, AJ | 1 |
| Feldman, SR | 1 |
| Boissy, RE | 1 |
| Visscher, M | 1 |
| DeLong, MA | 1 |
| Clarys, P | 1 |
| Barel, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Solar Lentigines Treatment With the Triple Combination Cream (Hydroquinone 4%, Tretinoin 0.05%, and Fluocinolone Acetonide 0.01%). Randomized, Double Blind, Controlled Trial.[NCT00975312] | Phase 2 | 22 participants (Actual) | Interventional | 2008-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for hydroquinone and Lentigo
| Article | Year |
|---|---|
Hyperpigmentation: an overview of the common afflictions.
Topics: Chemexfoliation; Cryotherapy; Dermatologic Agents; Dicarboxylic Acids; Humans; Hydroquinones; Hyperp | 2004 |
4 trials available for hydroquinone and Lentigo
| Article | Year |
|---|---|
Triple combination as adjuvant to cryotherapy in the treatment of solar lentigines: investigator-blinded, randomized clinical trial.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Chemotherapy, Adjuvant; Cryotherapy; | 2015 |
A Prospective Trial Comparing Q-Switched Ruby Laser and a Triple Combination Skin-Lightening Cream in the Treatment of Solar Lentigines.
Topics: Aged; Dexamethasone; Drug Combinations; Erythema; Female; Hand Dermatoses; Humans; Hydroquinones; La | 2016 |
Analytic quantification of solar lentigines lightening by a 2% hydroquinone-cyclodextrin formulation.
Topics: Administration, Topical; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Fema | 2003 |
Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Anisoles; Double-Blind Method; Drug Thera | 2004 |
4 other studies available for hydroquinone and Lentigo
| Article | Year |
|---|---|
Efficacy of hydroquinone-free skin-lightening cream for photoaging.
Topics: Administration, Cutaneous; Adult; Aged; California; Dermatologic Agents; Drug Combinations; Female; | 2013 |
Silicone sheet containing all-trans retinoic acid and hydroquinone for the treatment of epidermal melanosis.
Topics: Adult; Aged; Antioxidants; Drug Therapy, Combination; Female; Humans; Hydroquinones; Keratolytic Age | 2013 |
DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency.
Topics: Agaricales; Animals; Arbutin; Cell Proliferation; Clinical Trials as Topic; Dose-Response Relationsh | 2005 |
Efficacy of topical treatment of pigmentation skin disorders with plant hydroquinone glucosides as assessed by quantitative color analysis.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Apiaceae; Ascorbic Acid; Benzoyl Peroxide; Citru | 1998 |